This is the first issue of a bi-annual pipeline report IPD will release in 2022.

​

In this report, IPD Analytics provides detailed summaries of key drugs nearing potential FDA approval in the coming months.

Our team of pharmacists, PhD scientists, and intellectual property attorneys continuously monitor and update our comprehensive pipeline intelligence database.

This report is used as a companion to our online Clinical Development Tracker, which provides up-to-date clinical pipeline information on thousands of products across various disease classes and therapeutic areas. In tandem, these reports deliver insight into trending classes that will affect the competitive landscape and your drug spend.

​

DOWNLOAD NOW